Paper35565396
Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression.
Chehade H and 7 others. Cancers (Basel), 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression. Papers, record 35565396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35565396
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26286584 | Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. | Breast Cancer Res | 2015 | https://conductscience.org/library/papers/26286584 | PubMed |
| 2 | 29113366 | E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29113366 | PubMed |
| 3 | 16767288 | [The adipose tissue as a regulatory center of the metabolism]. | Arq Bras Endocrinol Metabol | 2006 | https://conductscience.org/library/papers/16767288 | PubMed |
| 4 | 23671428 | Biochemistry of adipose tissue: an endocrine organ. | Arch Med Sci | 2013 | https://conductscience.org/library/papers/23671428 | PubMed |
| 5 | 15890779 | Serum protein markers for early detection of ovarian cancer. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15890779 | PubMed |
| 6 | 23830918 | Anoikis molecular pathways and its role in cancer progression. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23830918 | PubMed |
| 7 | 31793192 | IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/31793192 | PubMed |
| 8 | 33512628 | Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer. | Int J Clin Oncol | 2021 | https://conductscience.org/library/papers/33512628 | PubMed |
| 9 | 10508482 | Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. | Int J Cancer | 1999 | https://conductscience.org/library/papers/10508482 | PubMed |
| 10 | 24803577 | The microenvironment matters: estrogen deficiency fuels cancer bone metastases. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24803577 | PubMed |
| 11 | 27440787 | Redefining the origin and evolution of ovarian cancer: a hormonal connection. | Endocr Relat Cancer | 2016 | https://conductscience.org/library/papers/27440787 | PubMed |
| 12 | 29191893 | Obesity and the tumor microenvironment. | Science | 2017 | https://conductscience.org/library/papers/29191893 | PubMed |
| 13 | 24605108 | Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/24605108 | PubMed |
| 14 | 10537332 | Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10537332 | PubMed |
| 15 | 31705064 | MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis. | Oncogene | 2020 | https://conductscience.org/library/papers/31705064 | PubMed |
| 16 | 29338446 | The latest animal models of ovarian cancer for novel drug discovery. | Expert Opin Drug Discov | 2018 | https://conductscience.org/library/papers/29338446 | PubMed |
| 17 | 31842876 | Nanotechnology advances towards development of targeted-treatment for obesity. | J Nanobiotechnology | 2019 | https://conductscience.org/library/papers/31842876 | PubMed |
| 18 | 33436287 | Is routine omentectomy of grossly normal omentum helpful in surgery for ovarian cancer? A look at the tumor microenvironment and its clinical implications. | Gynecol Oncol | 2021 | https://conductscience.org/library/papers/33436287 | PubMed |
| 19 | 34518593 | Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass. | Sci Rep | 2021 | https://conductscience.org/library/papers/34518593 | PubMed |
| 20 | 30765860 | Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. | Oncogene | 2019 | https://conductscience.org/library/papers/30765860 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939672 | Adipocytes Protect Ovarian Cancer Cells from Ferroptosis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939672 | PubMed |
| 42830884 | VEGF-Leptin Crosstalk in Breast and Ovarian Cancer: Drivers of Angiogenesis and Progression. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42830884 | PubMed |
| 42621564 | Diversity within ovarian cancer subtypes and their tumor microenvironment. | Front Oncol | 2026 | https://conductscience.org/library/papers/42621564 | PubMed |
| 42121893 | Punicic Acid in Ovarian Cancer: Anticancer Activity and Mechanistic Insights. | Cells | 2026 | https://conductscience.org/library/papers/42121893 | PubMed |
| 41284359 | Two Faces of Greater Omentum. | Compr Physiol | 2025 | https://conductscience.org/library/papers/41284359 | PubMed |
| 40369674 | Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | https://conductscience.org/library/papers/40369674 | PubMed |
| 40136652 | Cross-Talk Between Cancer and Its Cellular Environment-A Role in Cancer Progression. | Cells | 2025 | https://conductscience.org/library/papers/40136652 | PubMed |
| 39478634 | TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer. | Adv Healthc Mater | 2025 | https://conductscience.org/library/papers/39478634 | PubMed |
| 39104719 | Adipose microenvironment promotes hypersialylation of ovarian cancer cells. | Front Oncol | 2024 | https://conductscience.org/library/papers/39104719 | PubMed |
| 38635891 | Omental Preadipocytes Stimulate Matrix Remodeling and IGF Signaling to Support Ovarian Cancer Metastasis. | Cancer Res | 2024 | https://conductscience.org/library/papers/38635891 | PubMed |
| 38540217 | Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540217 | PubMed |
| 38426604 | Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer. | Int J Mol Med | 2024 | https://conductscience.org/library/papers/38426604 | PubMed |
| 37435088 | Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/37435088 | PubMed |
| 36661732 | Current Update on PET/MRI in Gynecological Malignancies-A Review of the Literature. | Curr Oncol | 2023 | https://conductscience.org/library/papers/36661732 | PubMed |
| 36644529 | The impact of omentectomy on cause-specific survival of Stage I-IIIA epithelial ovarian cancer: A PSM-IPTW analysis based on the SEER database. | Front Surg | 2022 | https://conductscience.org/library/papers/36644529 | PubMed |
Genes55
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35565396
GET https://conductscience.org/api/papers/v1/35565396/references?page=2